GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Breakout Stocks of Week 29

NASDAQ was up last week (week 28) by 0.428% ending at 14,701.92 points after gaining 62.59 points during the week. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are CGI Group Inc NYSE:GIB. This stock has had a buy signal since Jul 09, 2021 when the price was $91.94 , but have so far fallen 0% to $91.94. Some other companies are on our watchlist to, among these are Kintara Therapeutics Inc. NASDAQ:KTRA Avid Technology NASDAQ:AVID Bank of Nova Scotia (The) NYSE:BNS and Stericycle NASDAQ:SRCL which all got a breakout pattern emerging.

Date Company Price Week 29
Jul 09, 2021 Cgi Group Inc $91.94 $90.86 -1.17%
Jul 09, 2021 Kintara Therapeutics Inc. $1.89 $1.60 -15.34%
Jul 09, 2021 Avid Technology $39.48 $37.65 -4.64%
Jul 09, 2021 Bank Of Nova Scotia (the) $63.40 $62.31 -1.72%
Jul 09, 2021 Stericycle $71.05 $69.46 -2.24%

CGI Group Inc

NYSE:GIB Buy Candidate Score: 4.91
Buy Candidate Score: 4.91 Jul 09, 2021

CGI Group IncThe CGI Group Inc stock price gained 1.68% on the last trading day (Friday, 9th Jul 2021), rising from $90.42 to $91.94. During the last trading day the stock fluctuated 1.86% from a day low at $90.32 to a day high of $92.00. The price has risen in 7 of the last 10 days and is up by 1.2% over the past 2 weeks. Volume fell on the last day by -12 thousand shares and in total, 110 thousand shares were bought and sold for approximately $10.15 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

On Feb 02, 2023, it was reported that RBC Capital gave GIB a "Outperform" grade with a "hold" action.

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for CGI Group Inc stock to perform well in the short-term.

About CGI Group Inc:
CGI Inc., together with its subsidiaries, provides information technology (IT) and business process services in Canada; Western, Southern, Central, and Eastern Europe; Australia; Scandinavia; Finland, Poland, and Baltics; the United States; the United Kingdom; and the Asia Pacific. Its services include the management of IT and business outsourcing, systems integration and consulting, and software solutions selling activities. The company also offers application development, integration and maintenance, testing, portfolio management, and modernization services; business consulting; and a suite of business process services designed to address the needs of specific industries, as well as IT infrastructure services. It serves clients operating in government, banking and capital market, health, utility, communication and media, oil and gas, retail, consumer and services, space, manufacturing, insurance, life sciences, retail and consumer service, and transportation and logistics sectors. The company was formerly known as CGI Group Inc. and changed its name to CGI Inc. in January 2019. CGI Inc. was founded in 1976 and is headquartered in Montreal, Canada.

Kintara Therapeutics Inc.

NASDAQ:KTRA Buy Candidate Score: 4.18
Buy Candidate Score: 4.18 Jul 09, 2021

Kintara Therapeutics Inc.The Kintara Therapeutics Inc. stock price gained 5.00% on the last trading day (Friday, 9th Jul 2021), rising from $1.80 to $1.89. During the last trading day the stock fluctuated 12.22% from a day low at $1.80 to a day high of $2.02. The price has fallen in 6 of the last 10 days and is down by -21.25% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 million more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $3.77 million.

On Jul 14, 2023, it was reported that Raymond James gave KTRA a "Outperform" grade with a "downgrade" action.

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Kintara Therapeutics Inc. stock to perform well in the short-term.

About Kintara Therapeutics Inc.:
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a photodynamic therapy for the treatment of cutaneous metastatic breast cancer. The company has a strategic collaboration with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. to manufacture and sell VAL-083 in China. The company was formerly known as DelMar Pharmaceuticals, Inc. and changed its name to Kintara Therapeutics, Inc. in August 2020. Kintara Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Diego, California.

Avid Technology

NASDAQ:AVID Buy Candidate Score: 3.94
Buy Candidate Score: 3.94 Jul 09, 2021

Avid TechnologyThe Avid Technology stock price gained 4.64% on the last trading day (Friday, 9th Jul 2021), rising from $37.73 to $39.48. During the last trading day the stock fluctuated 4.72% from a day low at $37.93 to a day high of $39.72. The price has been going up and down for this period, and there has been a 0.74% gain for the last 2 weeks. Volume fell on the last day by -106 thousand shares and in total, 291 thousand shares were bought and sold for approximately $11.49 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Avid Technology stock to perform well in the short-term.

About Avid Technology:
Avid Technology, Inc., together with its subsidiaries, develops, markets, sells, and supports software and integrated solutions for video and audio content creation, management, and distribution worldwide. The company's video products and solutions include the Media Composer, a cloud-enabled solution used to edit video content; Avid NEXIS shared storage systems; Maestro solutions for the integration of virtual sets, augmented reality, and video wall control into existing workflows; AirSpeed 5000 and AirSpeed 5500 on-air server solutions; and MediaCentral, a media production suite. Its audio products and solutions comprise Pro Tools digital audio software solutions to facilitate the audio production process; Sibelius solution to create, edit, and publish musical scores; S6 line of complementary control surfaces and consoles; S1 and S4 audio control surfaces; and VENUE | S6L live sound system for mixing audio for live sound reinforcement. The company also provides Avid Link, a mobile application to connect with other artists, producers, mixers, composers, editors, videographers, movie makers, and graphic designers; FastServe video server that assists broadcasters in making the move to UHD and IP based workflows with a new and modular architecture; and hardware products, such as I/O devices, interfaces, and audio and video processing equipment. In addition, it offers various maintenance contracts and support services; professional services, such as workflow design and consulting, program and project management, system installation and commissioning, and custom development and role-based product level training; and public and private training to customers and alliance partners, as well as develops and licenses curriculum content for use by third party Avid Learning partners to deliver training to customers, users, and alliance partners. The company was incorporated in 1987 and is headquartered in Burlington, Massachusetts.

Bank of Nova Scotia (The)

NYSE:BNS Buy Candidate Score: 3.09
Buy Candidate Score: 3.09 Jul 09, 2021

Bank of Nova Scotia (The)The Bank of Nova Scotia (The) stock price gained 2.01% on the last trading day (Friday, 9th Jul 2021), rising from $62.15 to $63.40. During the last trading day the stock fluctuated 1.29% from a day low at $62.67 to a day high of $63.48. The price has fallen in 6 of the last 10 days and is down by -2.63% for this period. Volume fell on the last day by -22 thousand shares and in total, 1 million shares were bought and sold for approximately $91.06 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

On Nov 30, 2022, it was reported that RBC Capital gave BNS a "Sector Perform" grade with a "hold" action.

Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.

About Bank of Nova Scotia (The):
The Bank of Nova Scotia provides various banking products and services in Canada, the United States, Mexico, Peru, Chile, Colombia, the Caribbean and Central America, and internationally. It operates in four segments: Canadian Banking, International Banking, Global Wealth Management, and Global Banking and Markets. The company offers financial advice and solutions, and day-to-day banking products, including debit and credit cards, chequing and saving accounts, investments, mortgages, loans, and insurance to individuals; and business banking solutions comprising lending, deposit, cash management, and trade finance solutions to small, medium, and large businesses, including automotive financing solutions to dealers and their customers. It also provides wealth management advice and solutions, including online brokerage, mobile investment, full-service brokerage, trust, private banking, and private investment counsel services; and retail mutual funds, exchange traded funds, liquid alternative funds, and institutional funds. In addition, the company offers international banking services for retail, corporate, and commercial customers; and lending and transaction, investment banking advisory, and capital markets access services to corporate customers. Further, it provides online, mobile, and telephone banking services. The company operates a network of 954 branches and approximately 3,766 automated banking machines in Canada; and approximately 1,300 branches and a network of contact and support center internationally. The Bank of Nova Scotia was founded in 1832 and is headquartered in Halifax, Canada.

Stericycle

NASDAQ:SRCL Buy Candidate Score: 2.95
Buy Candidate Score: 2.95 Jul 09, 2021

StericycleThe Stericycle stock price gained 0.780% on the last trading day (Friday, 9th Jul 2021), rising from $70.50 to $71.05. During the last trading day the stock fluctuated 1.13% from a day low at $70.61 to a day high of $71.41. The price has risen in 6 of the last 10 days but is still down by -0.06% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 112 thousand more shares were traded than the day before. In total, 273 thousand shares were bought and sold for approximately $19.40 million.

On Feb 29, 2024, it was reported that RBC Capital gave SRCL a "Outperform" grade with a "hold" action.

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Stericycle stock to perform well in the short-term period.

About Stericycle:
Stericycle, Inc., together with its subsidiaries, provides regulated and compliance solutions in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including sharps disposable and management solutions; pharmaceutical waste services; hazardous waste disposal; maritime waste services, such as seaport and airport waste; and compliance programs under the Steri-Safe, Clinical Services, First Practice Management, SeguriMed, and EnviroAssure brand names. It also provides secure information destruction services, including document and hard drive destruction services under the Shred-it brand; and communication solutions, such as appointment reminders, secure messaging, event registration, and other communications specifically for hospitals and integrated delivery networks. The company serves healthcare businesses, including hospitals, physician and dental practices, outpatient clinics, long-term care facilities, etc.; retailers and manufacturers; financial and professional service providers; governmental entities; and other businesses. Stericycle, Inc. was incorporated in 1989 and is headquartered in Bannockburn, Illinois.

.

StockInvest.usStock Podcast